(Q61727985)

English

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally (English)

0 references

0 references

0 references

United States of America

0 references

main subject

Mesenchymal stem cells

0 references

research site

Icahn School of Medicine at Mount Sinai

0 references

minimum age

18 year

0 references

maximum age

70 year

0 references

study type

expanded access

0 references

Identifiers

ClinicalTrials.gov ID

NCT03822858

0 references

(Q61727985)

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)